Skip to search formSkip to main contentSkip to account menu

amlexanox

Known as: 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3b)pyridine-3-carboxylic acid, 5H-(1)Benzopyrano(2,3-b)pyridine-3-carboxylic acid, 2-amino-7-(1-methylethyl)-5-oxo-, Amoxanox 
An anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and release of inflammatory mediators, including leukotrienes and histamine, from mast… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Obesity: Teaching an old drug new tricks—amlexanox targets inflammation to improve metabolic dysfunction 
2012
2012
Prothymosin alpha (ProTα), a nuclear protein devoid of signal sequence, has been shown to possess a number of cellular functions… 
2011
2011
Background: Recurrent aphthous ulceration or recurrent aphthous stomatitis is the most common oral mucosal disease. Aims… 
2011
2011
A novel and sensitive stability indicating RP-HPLC method has been developed for the quantitative determination of amlexanox in… 
2009
2009
Objective:To establish a method for determination of related substances of amlexanox and its content in paste.Methods:The samples… 
1998
1998
Miscanthus sinensis M. sinensis i. v. i.p. M. sinensis i.p. M. sinensis 
1989
1989
The effect of amlexanox on the non-immunological or immunological release of histamine or leukotrienes (LTs) from passively…